Akshay Desai
Overview
Explore the profile of Akshay Desai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Solomon S, Vaduganathan M, Claggett B, Packer M, Zile M, Swedberg K, et al.
Circulation
. 2019 Nov;
141(5):352-361.
PMID: 31736342
Background: While disease-modifying therapies exist for heart failure (HF) with reduced left ventricular ejection fraction (LVEF), few options are available for patients in the higher range of LVEF (>40%). Sacubitril/valsartan...
12.
Castro R, Joyce E, Lakdawala N, Stewart G, Nohria A, Givertz M, et al.
Clin Cardiol
. 2019 Oct;
42(12):1181-1188.
PMID: 31571248
Background: Patient limitations guide selection of heart failure therapies, for which indications often specify New York Heart Association Class. Objectives: To determine the extent of patient-reported limitations during daily activities...
13.
Vest A, Chan M, Deswal A, Givertz M, Lekavich C, Lennie T, et al.
J Card Fail
. 2019 Mar;
25(5):380-400.
PMID: 30877038
Dietary guidance for patients with heart failure (HF) has traditionally focused on sodium and fluid intake restriction, but dietary quality is frequently poor in patients with HF and may contribute...
14.
Bravo P, Bergmark B, Vita T, Taqueti V, Gupta A, Seidelmann S, et al.
Eur Heart J
. 2017 Dec;
39(4):316-323.
PMID: 29236988
Aims: Cardiac allograft vasculopathy (CAV) is a leading cause of death in orthotopic heart transplant (OHT) survivors. Effective non-invasive screening methods are needed. Our aim was to investigate the added...
15.
Kristensen S, Jhund P, Mogensen U, Rorth R, Abraham W, Desai A, et al.
Circ Heart Fail
. 2017 Oct;
10(10).
PMID: 29018174
Background: Patients with heart failure (HF) and atrial fibrillation (AF) have higher circulating levels of NT-proBNP (N-terminal pro-B-type natriuretic peptide) than HF patients without AF. There is uncertainty about the...
16.
Solomon S, Claggett B, Packer M, Desai A, Zile M, Swedberg K, et al.
JACC Heart Fail
. 2016 Jul;
4(10):816-822.
PMID: 27395349
Objectives: This study assessed whether the benefit of sacubtril/valsartan therapy varied with clinical stability. Background: Despite the benefit of sacubitril/valsartan therapy shown in the PARADIGM-HF (Prospective Comparison of ARNI with...
17.
Joyce E, Chung C, Badloe S, Odutayo K, Desai A, Givertz M, et al.
JACC Heart Fail
. 2016 Feb;
4(3):184-93.
PMID: 26874379
Objectives: The relative contribution of heart failure (HF) compared with other medical and nonmedical factors on diminished quality of life (QOL) across subtypes with reduced, better, and preserved left ventricular...
18.
Zipes D, Calkins H, Daubert J, Ellenbogen K, Field M, Fisher J, et al.
Circ Arrhythm Electrophysiol
. 2015 Sep;
8(6):1522-51.
PMID: 26386016
No abstract available.
19.
Solomon S, Claggett B, Lewis E, Desai A, Anand I, Sweitzer N, et al.
Eur Heart J
. 2015 Sep;
37(5):455-62.
PMID: 26374849
Aims: While mineralocorticoid receptor antagonists (MRAs) have been shown to benefit patients with reduced left ventricular ejection fraction (LVEF), spironolactone did not reduce the primary endpoint of cardiovascular death, heart...
20.
McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, et al.
Eur Heart J
. 2014 Nov;
36(7):434-9.
PMID: 25416329
Aims: Although active-controlled trials with renin–angiotensin inhibitors are ethically mandated in heart failure with reduced ejection fraction, clinicians and regulators often want to know how the experimental therapy would perform...